Mitchell E. Reff

1.9k citations

41 papers · 1.2k indexed · h-index 21

Radiology, Nuclear Medicine and Imaging top 2%
- Monoclonal and Polyclonal Antibodies Research 20
Immunology top 10%
- T-cell and B-cell Immunology 7
- Immune Cell Function and Interaction 4
Immunology and Allergy top 5%
Molecular Biology top 10%
- Glycosylation and Glycoproteins Research 13
- RNA and protein synthesis mechanisms 6
- Protein purification and stability 5
- RNA modifications and cancer 3
Biotechnology top 10%
Cancer Research
- Protease and Inhibitor Mechanisms 5

Co-authors: Darrell R. Anderson Michael J. LaBarre Liying Jiang Julian Davies Kandasamy Hariharan David S. Pfarr Gary R. Braslawsky Roland Newman
Cited by: Radiology, Nuclear Medicine and Imaging Immunology Immunology and Allergy
Journals: Biotechnology and Bioengineering (3 papers)Nucleic Acids Research (3 papers)Infection and Immunity (2 papers)
Partner nations: United States Japan Belgium

In The Last Decade

Mitchell E. Reff

40 papers receiving 1.2k citations

Peers

Countries citing papers authored by Mitchell E. Reff

Since Specialization

Citations

This map shows the geographic impact of Mitchell E. Reff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell E. Reff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell E. Reff more than expected).

Fields of papers citing papers by Mitchell E. Reff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell E. Reff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell E. Reff. The network helps show where Mitchell E. Reff may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mitchell E. Reff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mitchell E. Reff Line = papers co-authored together Mitchell E. Reff links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Combination of Two Insulin-Like Growth Factor-I Receptor Inhibitory Antibodies Targeting Distinct Epitopes Leads to an Enhanced Antitumor Response Molecular Cancer Therapeutics ·Jianying Dong,Stephen J. Demarest,Arlene Sereno,Katrina Mae C. Legaspi,Emma Langley,宮田倫明,Azrin Rahman,V.C. Giri,Ingrid B.J. Joseph,Scott Glaser,Steffan N. Ho,Mitchell E. Reff,Kandasamy Hariharan	2010	48
2	Enhanced cell culture performance using inducible anti‐apoptotic genes E1B‐19K and Aven in the production of a monoclonal antibody with Chinese hamster ovary cells Biotechnology and Bioengineering ·Bruno Figueroa,Eric Ailor,Douglas G. Osborne,J. Marie Hardwick,Mitchell E. Reff,Michael J. Betenbaugh	2006	79
3	Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects Journal of Allergy and Clinical Immunology ·Jill A. Poole,Jianfeng Meng,Mitchell E. Reff,Mary Spellman,Lanny J. Rosenwasser	2005	61
4	Novel Antibody Hinge Regions for Efficient Production of CH2 Domain-deleted Antibodies Journal of Biological Chemistry ·Scott Glaser,Kenichirou Baba,Manju Mohan Mukherjee,Parsa Hashemi‐Alavi,Daniel Perret,Mitchell E. Reff	2005	2
5	Anti-CD23 monoclonal antibody inhibits germline Cε transcription in B cells International Immunopharmacology ·Г. Баранов,Takehiko Nakamura,William S. Kloetzer,Mitchell E. Reff	2002	22
6	Chromosome localization and gene‐copy‐number quantification of three random integrations in Chinese‐hamster ovary cells and their amplified cell lines using fluorescence in situ hybridization Biotechnology and Applied Biochemistry ·Julian Davies,Mitchell E. Reff	2001	20
7	A review of modifications to recombinant antibodies: attempt to increase efficacy in oncology applications Critical Reviews in Oncology/Hematology ·Mitchell E. Reff,Paul L. De Vries	2001	41
8	Future Approaches for Treating Hematologic Disease Current Pharmaceutical Biotechnology ·Mitchell E. Reff,Gary R. Braslawsky,Nabil Hanna	2001	1
9	Modification of the Fc Region of a Primatized IgG Antibody to Human CD4 Retains Its Ability to Modulate CD4 Receptors but Does Not Deplete CD4+ T Cells in Chimpanzees Clinical Immunology ·Roland Newman,Kandasamy Hariharan,Mitchell E. Reff,宏志田澤,Gary R. Braslawsky,钱良玉,Nabil Hanna,Peter J. Bugelski,Michael Brigham‐Burke,Carl Crysler,Robert Gagnon,Santhosh K. Amanchi,Michael L. Doyle,Preston Hensley,Manjula Reddy,Raymond W. Sweet,Alemseged Truneh	2001	45
10	Efficacy of the anti-angiogenic approach to solid tumors Drug Discovery Today ·Mitchell E. Reff	2001	1
11	Elimination of Fc Receptor-Dependent Effector Functions of a Modified IgG4 Monoclonal Antibody to Human CD4 The Journal of Immunology ·Manjula Reddy,Gibra Teixeira,Margery A. Chaikin,Joachim Lippold,Jacqueline Fishman‐Lobell,Ping Tsui,Diana Patricia Martínez Caicedo,Michael L. Doyle,Michael Brigham‐Burke,Darrell R. Anderson,Mitchell E. Reff,Roland Newman,Nabil Hanna,Raymond W. Sweet,Alemseged Truneh	2000	97
12	Measurement of protein interaction bioenergetics: Application to structural variants of anti-sCD4 antibody Methods in enzymology on CD-ROM/Methods in enzymology ·Michael L. Doyle,Michael Brigham‐Burke,Michael N. Blackburn,Ian Brooks,Thomas M. Smith,Roland Newman,Mitchell E. Reff,Walter F. Stafford,Raymond W. Sweet,Alemseged Truneh,Preston Hensley,Daniel J. O’Shannessy	2000	15
13	Integrin-dependent Tyrosine Phosphorylation and Growth Regulation by Vav Cell adhesion and communications/Cell adhesion and communication/Cell adhesion & communication ·Ilana Yron,Marcel Deckert,Mitchell E. Reff,C. Golden,Martin A. Schwartz,Amnon Altman	1999	29
14	“Primatization” of Recombinant Antibodies for Immunotherapy of Human Diseases: A Macaque/Human Chimeric Antibody Against Human CD4 Nature Biotechnology ·Roland Newman,Luis Sylvester,Darrell R. Anderson,А.В. Ершов,Paul L. De Vries,D. E. Jacobsen,TONI FEDOROWSKI,Mitchell E. Reff,Steve Shuey,Nabil Hanna	1992	66
15	Production in Eukaryotic Cells and Characterization of Four Hybrids of Tissue-Type and Urokinase-Type Plasminogen Activators DNA ·L Piérard,L.F.S. Beebe,Mitchell E. Reff,Alex Bollen	1989	5
16	Alterations in the pre-mRNA topology of the bovine growth hormone polyadenylation region decrease poly(A) site efficiency Nucleic Acids Research ·Tadeja Jere Jakulin,Mitchell E. Reff,Ingrid C. Deckman	1989	17
17	DHFR Coamplification of t-PA in DHFR ⁺ Bovine Endothelial Cells: In Vitro Characterization of the Purified Serine Protease DNA ·横田裕行,Raymond W. Sweet,James P. Noveral,David S. Pfarr,John J. Trill,Ronald J. Shebuski,Barry A. Berkowitz,李逃昌,S.T. Franklin,Mitchell E. Reff	1988	27
18	Characterization of a chimaeric plasminogen activator obtained by insertion of the second kringle structure of tissue-type plasminogen activator (amino acids 173 through 262) between residues Asp130 and Ser139 of urokinase-type plasminogen activator Thrombosis Research ·H.R. Lijnen,Luc Piérard,Mitchell E. Reff,Dirk Gheysen	1988	9
19	Differential Effects of Polyadenylation Regions on Gene Expression in Mammalian Cells DNA ·David S. Pfarr,Greg Carlin,Richard P. Woychik,Fritz Rottman,Martin Rosenberg,Mitchell E. Reff	1986	64
20	A Highly Modular Cloning Vector for the Analysis of Eukaryotic Genes and Gene Regulatory Elements DNA ·David S. Pfarr,Ganesh M. Sathe,Mitchell E. Reff	1985	29

About Mitchell E. Reff

Mitchell E. Reff is a scholar working on Radiology, Nuclear Medicine and Imaging, Biotechnology and Immunology, having authored 41 papers that have together received 1.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (20 papers), Glycosylation and Glycoproteins Research (13 papers), T-cell and B-cell Immunology (7 papers), RNA and protein synthesis mechanisms (6 papers), Protein purification and stability (5 papers), Protease and Inhibitor Mechanisms (5 papers), Immune Cell Function and Interaction (4 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (555 citations), Immunology (387 citations) and Immunology and Allergy (103 citations). Mitchell E. Reff has collaborated with scholars based in United States, Japan and Belgium. Frequent co-authors include Darrell R. Anderson, Michael J. LaBarre, Liying Jiang, Julian Davies, Kandasamy Hariharan, David S. Pfarr, Gary R. Braslawsky, Roland Newman, Nabil Hanna and Raymond W. Sweet. Their work appears in journals such as Biotechnology and Bioengineering, Nucleic Acids Research, Infection and Immunity, Journal of Biological Chemistry and Journal of Allergy and Clinical Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact